148 related articles for article (PubMed ID: 37750036)
41. Effect of cyclophosphamide pretreatment on defective delayed-type hypersensitivity in autoimmune-prone MRL mice.
Okuyama H; Matsunaga T; Kobayashi S; Hashimoto Y; Kawaguchi Y; Yamamoto K
Int Arch Allergy Appl Immunol; 1989; 88(4):394-401. PubMed ID: 2785972
[TBL] [Abstract][Full Text] [Related]
42. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
[TBL] [Abstract][Full Text] [Related]
43. Neuromuscular histopathology in (New Zealand black x New Zealand white)F1 and MRL-lpr/lpr autoimmune mice: models for skeletal muscle involvement in connective tissue disease.
Rosenberg NL
Arthritis Rheum; 1988 Jun; 31(6):806-11. PubMed ID: 3382453
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
45. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
Xu JP; Li X; Mori E; Guo MW; Mori T
Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647
[TBL] [Abstract][Full Text] [Related]
47. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
48. Increase in potential activities of protein phosphatases PP1 and PP2A in lymphoid tissues of autoimmune MRL/MpJ-lpr/lpr mice.
Matsuzawa S; Tamura T; Mizuno Y; Kobayashi S; Okuyama H; Tsukitani Y; Uemura D; Kikuchi K
J Biochem; 1992 Apr; 111(4):472-7. PubMed ID: 1319990
[TBL] [Abstract][Full Text] [Related]
49. Intersection of Immunity, Metabolism, and Muscle Regeneration in an Autoimmune-Prone MRL Mouse Model.
Ngo TB; Josyula A; DeStefano S; Fertil D; Faust M; Lokwani R; Sadtler K
Adv Sci (Weinh); 2024 Mar; 11(11):e2306961. PubMed ID: 38192168
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-inducible factor 1α (HIF-1α) is a major determinant in the enhanced function of muscle-derived progenitors from MRL/MpJ mice.
Sinha KM; Tseng C; Guo P; Lu A; Pan H; Gao X; Andrews R; Eltzschig H; Huard J
FASEB J; 2019 Jul; 33(7):8321-8334. PubMed ID: 30970214
[TBL] [Abstract][Full Text] [Related]
51. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
52. Effects of dietary omega3 and omega6 lipids and vitamin E on proliferative response, lymphoid cell subsets, production of cytokines by spleen cells, and splenic protein levels for cytokines and oncogenes in MRL/MpJ-lpr/lpr mice.
Venkatraman JT; Chu WC
J Nutr Biochem; 1999 Oct; 10(10):582-97. PubMed ID: 15539254
[TBL] [Abstract][Full Text] [Related]
53. The histopathological features of the surgical endometriosis model using systemic autoimmune disease-prone mice.
Hosotani M; Akita M; Ueda H; Watanabe T
J Vet Med Sci; 2023 Jan; 85(1):1-8. PubMed ID: 36436950
[TBL] [Abstract][Full Text] [Related]
54. [A study on the mechanism of activation of peritoneal exudate macrophages from MRL/MpJ-lpr/lpr mice].
Hashimoto Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):781-90. PubMed ID: 2853694
[TBL] [Abstract][Full Text] [Related]
55. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
56. Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.
Tsukahara T; Makino Y; Fujii T; Ogawa M; Saisho H; Hamano Y; Ueda S; Akikusa B; Danoff TM
Clin Immunol; 2002 Apr; 103(1):89-97. PubMed ID: 11987989
[TBL] [Abstract][Full Text] [Related]
57. Elevated plus maze behavior, auditory startle response, and shock sensitivity in predisease and in early stage autoimmune disease MRL/lpr mice.
Nielsen DM; Crnic LS
Brain Behav Immun; 2002 Feb; 16(1):46-61. PubMed ID: 11846440
[TBL] [Abstract][Full Text] [Related]
58. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
Lenda DM; Stanley ER; Kelley VR
J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
[TBL] [Abstract][Full Text] [Related]
59. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC
Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
